Table 2 Demographic and baseline clinical characteristics of 200 baseline and 132 follow-up study participants in the mUTIMA cohort. Percentages/proportions are represented in parentheses. P-values are calculated using t-tests, chi-squared tests, and two-proportion z-test for continuous, categorical, and binary variables, respectively
Baseline (n = 200) | Year 2 (n = 132) | P (Baseline vs. Year 2) | |
|---|---|---|---|
Age, years (mean ± SD) | 56 ± 6.5 | 55 ± 6.5 | 0.39 |
Age group categories (n) | 0.80 | ||
45–54 | 94 (47) | 67 (51) | |
55–64 | 86 (43) | 55 (42) | |
65 + | 20 (10) | 10 (8) | |
ASCVD risk group (n) | 0.72 | ||
Low (< 5%) | 62 (31) | 48 (36) | |
Borderline (5–7.5%) | 39 (20) | 26 (20) | |
Intermediate (7.5–10%) | 33 (17) | 21 (16) | |
High (> 10%) | 66 (33) | 37 (28) | |
Past Medical History (n) | |||
Diabetes | 71 (36) | 40 (30) | 0.39 |
Hypertension | 170 (85) | 113 (86) | 0.99 |
Current smoker | 8 (4) | 7 (5) | 0.77 |
BMI | 0.93 | ||
Normal | 45 (23) | 31 (23) | |
Overweight | 66 (33) | 47 (36) | |
Obese | 86 (43) | 52 (39) | |
Underweight | 3 (2) | 2 (2) | |
Waist-to-hip ratio (mean ± SD) | 0.91 ± 0.10 | 0.91 ± 0.09 | 0.71 |
Abdominal obesity (high WHR†) | 139 (70) | 93 (70) | 0.95 |
Chronic kidney disease | 25 (13) | 11 (8) | 0.31 |
GFR (mean ± SD) | 100 ± 23.2 | 103 ± 18.8 | 0.19 |
Abnormal urine ACR ‡ | 51 (26) | 24 (12) | 0.15 |
HIV | 100 (50) | 68 (52) | 0.87 |
High total cholesterol | 114 (57) | 71 (54) | 0.64 |
High low-density lipoprotein cholesterol | 111 (56) | 70 (53) | 0.74 |
Low high-density lipoprotein cholesterol | 126 (63) | 82 (62) | 0.96 |